+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Transfusion Diagnostics Market by Product (Consumables & Accessories, Instruments, Reagents & Kits), Technology (Nucleic Acid Testing, Pathogen Reduction Technology, Serological Testing), End User, Application - Global Forecast 2025-2030- Product Image
Blood Transfusion Diagnostics Market by Product (Consumables & Accessories, Instruments, Reagents & Kits), Technology (Nucleic Acid Testing, Pathogen Reduction Technology, Serological Testing), End User, Application - Global Forecast 2025-2030- Product Image
Sale

Blood Transfusion Diagnostics Market by Product (Consumables & Accessories, Instruments, Reagents & Kits), Technology (Nucleic Acid Testing, Pathogen Reduction Technology, Serological Testing), End User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010986
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Blood Transfusion Diagnostics Market is advancing rapidly as stakeholders prioritize innovation, efficiency, and resilience across global healthcare systems. In an environment marked by technological evolution and shifting regulations, senior decision-makers require clear, actionable intelligence to inform their strategies and investments.

Market Snapshot: Blood Transfusion Diagnostics Market Size & Growth

The Blood Transfusion Diagnostics Market grew from USD 3.86 billion in 2024 to USD 4.25 billion in 2025. With an expected CAGR of 9.83%, the market is projected to reach USD 6.77 billion by 2030. This robust outlook reflects mounting demand for advanced diagnostics, as healthcare providers continually seek faster, more accurate, and reliable solutions to underpin patient safety and drive operational improvements.

Scope & Segmentation of the Blood Transfusion Diagnostics Market

  • Product: Consumables & accessories include microplates and pipette tips. Instrument options feature NAT analyzers, pathogen reduction systems, and serology analyzers. Reagents & kits encompass amplification reagents, antibody reagents, and DNA extraction kits.
  • Technology: Nucleic acid testing covers PCR, real time PCR, and transcription mediated amplification. Pathogen reduction technology utilizes amotosalen, methylene blue, and riboflavin. Serological testing methods include CLIA, ELISA, and lateral flow assays.
  • End User: The market serves hospital blood banks, independent laboratories, and research institutes.
  • Application: Key uses are donation screening (immunohematology testing, viral marker screening), quality control (external proficiency testing, internal quality control), and transfusion safety (blood group typing, pathogen inactivation).
  • Regional Coverage: Analysis extends across the Americas (U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the U.K., Germany, France, UAE, Saudi Arabia, South Africa, and others), and Asia-Pacific (China, India, Japan, Australia, Southeast Asia, and more).
  • Leading Companies: Ortho Clinical Diagnostics, Grifols, Thermo Fisher Scientific, Immucor, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Abbott, Siemens Healthineers, and bioMérieux.

Key Takeaways for Senior Decision-Makers

  • Rapid adoption of molecular assays and pathogen reduction systems is reshaping diagnostic workflows, supporting faster clinical decisions and improved patient outcomes.
  • Regulatory harmonization efforts, especially in Europe, are encouraging the standardization and interoperability of testing protocols, driving vendor alignment and operational streamlining.
  • Emerging technologies, including AI-powered analytics, are enabling predictive quality control, ensuring labs can proactively address operational challenges and maintain high reliability.
  • Strategic alliances and integration across the value chain—spanning instrument developers, reagent suppliers, and data analytics providers—are fostering comprehensive, end-to-end diagnostic ecosystems.
  • Regional variations present both opportunities and complexity; developed markets focus on automation, while emerging areas prioritize access, scalability, and cost-effectiveness in blood diagnostics.
  • Consolidation and co-development initiatives among industry leaders are accelerating product innovation, reducing time to market for next-generation platforms, and ensuring alignment with evolving clinical needs.

Tariff Impact on U.S. Blood Transfusion Diagnostics

The 2025 implementation of new U.S. tariffs on diagnostic reagents, kits, and instrumentation components is altering procurement dynamics. Laboratories are contending with increased acquisition costs, longer lead times, and heightened budgetary pressures. Procurement teams are reevaluating sourcing strategies, including local contract manufacturing and tariff classification reviews, to secure critical supplies while maintaining testing continuity. These responses are crucial for preserving operational resilience and safeguarding patient safety amid shifting trade policies.

Methodology & Data Sources

This report applies a multi-tiered approach, beginning with extensive secondary research across academic journals, regulatory documents, and technical publications. Primary insights were captured via structured interviews with industry executives, laboratory directors, and regulatory experts. Data triangulation and expert feedback loops minimize bias, ensuring reliable, context-driven intelligence for stakeholders.

Why This Report Matters for Industry Leaders

  • Supports informed decision-making by offering comprehensive, up-to-date insights on technology evolution, regulatory changes, and regional dynamics in the blood transfusion diagnostics sector.
  • Equips executive teams with actionable strategies to enhance supply chain resilience, operational agility, and innovation pipelines in an evolving healthcare landscape.
  • Enables assessment of market positioning, competitor activity, and growth catalysts, ensuring investments align with both short-term needs and long-term clinical demand.

Conclusion

The Blood Transfusion Diagnostics Market is advancing through innovation, regulatory change, and collaborative strategies. Senior decision-makers who leverage data-driven insights and agile approaches will be well-positioned to ensure operational excellence and sustained growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Implementation of next-generation nucleic acid testing platforms to enhance pathogen detection sensitivity in blood donations
5.2. Adoption of artificial intelligence and machine learning algorithms for automated blood typing and crossmatching workflows in transfusion centers
5.3. Integration of blockchain-enabled traceability solutions to secure the blood supply chain and mitigate transfusion-related safety risks
5.4. Expansion of microfluidic point-of-care diagnostic devices for rapid bedside blood compatibility testing in emergency and rural settings
5.5. Development of high-throughput multiplexed immunoassays for simultaneous detection of multiple transfusion-transmissible infections during donor screening
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Transfusion Diagnostics Market, by Product
8.1. Introduction
8.2. Consumables & Accessories
8.2.1. Microplates
8.2.2. Pipette Tips
8.3. Instruments
8.3.1. Nat Analyzers
8.3.2. Pathogen Reduction Systems
8.3.3. Serology Analyzers
8.4. Reagents & Kits
8.4.1. Amplification Reagents
8.4.2. Antibody Reagents
8.4.3. Dna Extraction Kits
9. Blood Transfusion Diagnostics Market, by Technology
9.1. Introduction
9.2. Nucleic Acid Testing
9.2.1. Pcr
9.2.2. Real Time Pcr
9.2.3. Transcription Mediated Amplification
9.3. Pathogen Reduction Technology
9.3.1. Amotosalen
9.3.2. Methylene Blue
9.3.3. Riboflavin
9.4. Serological Testing
9.4.1. Clia
9.4.2. Elisa
9.4.3. Lateral Flow Assays
10. Blood Transfusion Diagnostics Market, by End User
10.1. Introduction
10.2. Hospital Blood Banks
10.3. Independent Laboratories
10.4. Research Institutes
11. Blood Transfusion Diagnostics Market, by Application
11.1. Introduction
11.2. Donation Screening
11.2.1. Immunohematology Testing
11.2.2. Viral Marker Screening
11.3. Quality Control
11.3.1. External Proficiency Testing
11.3.2. Internal Quality Control
11.4. Transfusion Safety
11.4.1. Blood Group Typing
11.4.2. Pathogen Inactivation
12. Americas Blood Transfusion Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Blood Transfusion Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Blood Transfusion Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Ortho Clinical Diagnostics, Inc.
15.3.2. Grifols, S.A.
15.3.3. Thermo Fisher Scientific Inc.
15.3.4. Immucor, Inc.
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. Danaher Corporation
15.3.7. F. Hoffmann-La Roche Ltd
15.3.8. Abbott Laboratories
15.3.9. Siemens Healthineers AG
15.3.10. bioMérieux SA
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BLOOD TRANSFUSION DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BLOOD TRANSFUSION DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BLOOD TRANSFUSION DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BLOOD TRANSFUSION DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 24. BLOOD TRANSFUSION DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 25. BLOOD TRANSFUSION DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 26. BLOOD TRANSFUSION DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BLOOD TRANSFUSION DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY MICROPLATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PIPETTE TIPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PIPETTE TIPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NAT ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NAT ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMPLIFICATION REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ANTIBODY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DNA EXTRACTION KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMOTOSALEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY AMOTOSALEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY METHYLENE BLUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY METHYLENE BLUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY RIBOFLAVIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY RIBOFLAVIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CLIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CLIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITAL BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY HOSPITAL BLOOD BANKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY IMMUNOHEMATOLOGY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY IMMUNOHEMATOLOGY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY VIRAL MARKER SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY VIRAL MARKER SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY EXTERNAL PROFICIENCY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY EXTERNAL PROFICIENCY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INTERNAL QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INTERNAL QUALITY CONTROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUP TYPING, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY BLOOD GROUP TYPING, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN INACTIVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN INACTIVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 161. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 162. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 163. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 164. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 165. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 166. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 167. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 168. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 169. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2024 (USD MILLION)
TABLE 172. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2025-2030 (USD MILLION)
TABLE 173. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2024 (USD MILLION)
TABLE 176. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2025-2030 (USD MILLION)
TABLE 177. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2024 (USD MILLION)
TABLE 182. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2025-2030 (USD MILLION)
TABLE 183. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 184. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 185. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2024 (USD MILLION)
TABLE 186. CANADA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 188. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 189. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 190. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 191. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2024 (USD MILLION)
TABLE 198. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2025-2030 (USD MILLION)
TABLE 199. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 200. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 201. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2024 (USD MILLION)
TABLE 202. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2025-2030 (USD MILLION)
TABLE 203. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2024 (USD MILLION)
TABLE 208. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2025-2030 (USD MILLION)
TABLE 209. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 210. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 211. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2024 (USD MILLION)
TABLE 212. MEXICO BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID TESTING, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PATHOGEN REDUCTION TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY SEROLOGICAL TESTING, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY DONATION SCREENING, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY QUALITY CONTROL, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY TRANSFUSION SAFETY, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM BLOOD TRANSFUSION DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2024 (USD MILLION)
T

Samples

Loading
LOADING...

Companies Mentioned

  • Ortho Clinical Diagnostics, Inc.
  • Grifols, S.A.
  • Thermo Fisher Scientific Inc.
  • Immucor, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • bioMérieux SA

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.25 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.77 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Blood Banking & Blood Products Market by Product Type (Apheresis Equipment, Blood Collection and Storage Systems, Blood Component Separators), Application (Immunohematology, Molecular Diagnostics, Quality Control), End User, Technology - Global Forecast 2025-2030 - Product Image

Blood Banking & Blood Products Market by Product Type (Apheresis Equipment, Blood Collection and Storage Systems, Blood Component Separators), Application (Immunohematology, Molecular Diagnostics, Quality Control), End User, Technology - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Blood Transfusion Diagnostics - Global Strategic Business Report - Product Image

Blood Transfusion Diagnostics - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Blood Transfusion Diagnostics Market Report 2025 - Product Image

Blood Transfusion Diagnostics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Donor Transfusion Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Donor Transfusion Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Blood Preparation Market by Product Type (Cryoprecipitate, Plasma, Platelets), Application (Surgical Transfusion, Therapeutic Transfusion), End User - Global Forecast 2025-2030 - Product Image

Blood Preparation Market by Product Type (Cryoprecipitate, Plasma, Platelets), Application (Surgical Transfusion, Therapeutic Transfusion), End User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From

About the Transfusion Diagnostics Market

The Transfusion Diagnostics market is a segment of the In Vitro Diagnostics (IVD) industry. It focuses on the development and production of diagnostic tests used to detect and monitor blood-borne diseases, such as HIV, hepatitis, and syphilis. These tests are used to ensure the safety of blood transfusions and to monitor the health of blood donors. Transfusion Diagnostics tests are used in hospitals, blood banks, and other healthcare settings. The Transfusion Diagnostics market is driven by the increasing demand for safe and reliable blood transfusions, as well as the need for improved patient safety. Additionally, the development of new technologies, such as molecular diagnostics, has enabled the development of more accurate and sensitive tests. Some companies in the Transfusion Diagnostics market include Abbott, Bio-Rad Laboratories, Becton Dickinson, Ortho Clinical Diagnostics, and Siemens Healthineers. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.